Proffered Paper: Utilising non-mutational drug-tolerance prolongs and improves targeted melanoma therapy. (July 2016) - Smith, M.P.; Brunton, H.; Rowling, E.J.; Girotti, M.R.; Marais, R.; Dummer, R.; Flaherty, K.T.; Cooper, Z.A.; Wargo, J.A.; Wellbrock, C.